London, UK (PRWEB) July 10, 2014
Deep Knowledge Ventures last week sponsored the inaugural 21st Century Medicine Forum on ‘Commercialising Longevity Research’ and welcomed a host of London-based investors, scientists and entrepreneurs to the London Bioscience Innovation Center for the event, organised by the UK’s Biogerontology Research Foundation and Aging Analytics Ltd. The meeting highlighted the need for both philanthropic support and investment in translational research for age-related disease, as well as the crucial role of social awareness of advances in regenerative and preventative medicine. This point was well made by attending actress, campaigner and international model, Katya Elizarova, who said:
“It’s clear that the most important thing is to support projects for preventing aging. If researchers are clever enough to develop methods to prevent age-related damage accumulating, it's much more likely that they will have an ability to treat with success”, adding, “If I, as a media person, can increase the awareness of what you are doing here today and involve as many people as I can, then I shall do it.”
The evening was marked by the announcement that former Chairman of the International Employee Benefits Association and pensions industry expert Geoffrey Furlonger is to join Aging Analytics as its new CEO. Deep Knowledge Ventures Senior Partner Dmitry Kaminskiy made the announcement during his talk on Impact Investment in Regenerative Medicine and highlighted Aging Analytics success in deploying its unique investor decision support software, VITAL (Validating Investment Tool for Advancing Life Sciences) and the publication of its first report, ‘Investing in Regenerative Medicine: Technology and Market Outlook’. Participants of the forum were handed out free copies of the report at the event. Introducing Geoffrey, Dmitry noted that under his leadership we could expect to see Aging Analytics draw attent
Copyright©2014 Vocus, Inc.
All rights reserved